Cargando…
Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study
Tuberculosis (TB) is a deadly infection and caused 1.4 million deaths in 2018. Assessing the geographic distribution of major lineages of Mycobacterium tuberculosis can contribute greatly to TB control. Mycobacterial interspersed repetitive unit variable number tandem repeat (MIRU-VNTR) typing is co...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404542/ https://www.ncbi.nlm.nih.gov/pubmed/32774869 http://dx.doi.org/10.1016/j.nmni.2020.100729 |
_version_ | 1783567149873233920 |
---|---|
author | Mousavi, S.M.J. Amini, S. Mirsaeidi, M. Dabiri, H. Hamzehloo, G. Goudarzi, H. Nasiri, M.J. |
author_facet | Mousavi, S.M.J. Amini, S. Mirsaeidi, M. Dabiri, H. Hamzehloo, G. Goudarzi, H. Nasiri, M.J. |
author_sort | Mousavi, S.M.J. |
collection | PubMed |
description | Tuberculosis (TB) is a deadly infection and caused 1.4 million deaths in 2018. Assessing the geographic distribution of major lineages of Mycobacterium tuberculosis can contribute greatly to TB control. Mycobacterial interspersed repetitive unit variable number tandem repeat (MIRU-VNTR) typing is commonly used to differentiate various lineages of M. tuberculosis. A total of 2747 clinical specimens were collected consecutively from October 2018 through June 2019. Clinical isolates were identified as M. tuberculosis using standard biochemical tests. The standard 15-locus MIRU-VNTR typing was used for the genotyping of clinical isolates. Drug susceptibility testing was performed using the conventional proportion method. From the collected specimens, 100 were culture positive for M. tuberculosis. Using MIRU-VNTR, 99 different patterns were detected among the 100 isolates. They were distributed in one cluster comprising two strains and 98 unique patterns. Most of our isolates were similar to New-1 and Delhi/CAS strains. Of the M. tuberculosis isolates, 83 (83.0%) were pan-susceptible and 17 (17.0%) were resistant to at least one drug. Our study showed that MIRU-VNTR is a useful method for studying the genetic diversity of M. tuberculosis isolates in different regional settings and will help the health authorities to construct a preventive programme for TB. |
format | Online Article Text |
id | pubmed-7404542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-74045422020-08-07 Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study Mousavi, S.M.J. Amini, S. Mirsaeidi, M. Dabiri, H. Hamzehloo, G. Goudarzi, H. Nasiri, M.J. New Microbes New Infect Original Article Tuberculosis (TB) is a deadly infection and caused 1.4 million deaths in 2018. Assessing the geographic distribution of major lineages of Mycobacterium tuberculosis can contribute greatly to TB control. Mycobacterial interspersed repetitive unit variable number tandem repeat (MIRU-VNTR) typing is commonly used to differentiate various lineages of M. tuberculosis. A total of 2747 clinical specimens were collected consecutively from October 2018 through June 2019. Clinical isolates were identified as M. tuberculosis using standard biochemical tests. The standard 15-locus MIRU-VNTR typing was used for the genotyping of clinical isolates. Drug susceptibility testing was performed using the conventional proportion method. From the collected specimens, 100 were culture positive for M. tuberculosis. Using MIRU-VNTR, 99 different patterns were detected among the 100 isolates. They were distributed in one cluster comprising two strains and 98 unique patterns. Most of our isolates were similar to New-1 and Delhi/CAS strains. Of the M. tuberculosis isolates, 83 (83.0%) were pan-susceptible and 17 (17.0%) were resistant to at least one drug. Our study showed that MIRU-VNTR is a useful method for studying the genetic diversity of M. tuberculosis isolates in different regional settings and will help the health authorities to construct a preventive programme for TB. Elsevier 2020-07-13 /pmc/articles/PMC7404542/ /pubmed/32774869 http://dx.doi.org/10.1016/j.nmni.2020.100729 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Mousavi, S.M.J. Amini, S. Mirsaeidi, M. Dabiri, H. Hamzehloo, G. Goudarzi, H. Nasiri, M.J. Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study |
title | Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study |
title_full | Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study |
title_fullStr | Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study |
title_full_unstemmed | Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study |
title_short | Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study |
title_sort | genotyping and drug susceptibility testing of mycobacterium tuberculosis in iran: a multi-centre study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404542/ https://www.ncbi.nlm.nih.gov/pubmed/32774869 http://dx.doi.org/10.1016/j.nmni.2020.100729 |
work_keys_str_mv | AT mousavismj genotypinganddrugsusceptibilitytestingofmycobacteriumtuberculosisiniranamulticentrestudy AT aminis genotypinganddrugsusceptibilitytestingofmycobacteriumtuberculosisiniranamulticentrestudy AT mirsaeidim genotypinganddrugsusceptibilitytestingofmycobacteriumtuberculosisiniranamulticentrestudy AT dabirih genotypinganddrugsusceptibilitytestingofmycobacteriumtuberculosisiniranamulticentrestudy AT hamzehloog genotypinganddrugsusceptibilitytestingofmycobacteriumtuberculosisiniranamulticentrestudy AT goudarzih genotypinganddrugsusceptibilitytestingofmycobacteriumtuberculosisiniranamulticentrestudy AT nasirimj genotypinganddrugsusceptibilitytestingofmycobacteriumtuberculosisiniranamulticentrestudy |